Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating activities
Net income	$ 33,030	$ 631,947
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	87,586	88,760
Amortization of deferred financing costs and debt discount	4,014	5,285
Straight-line rent revenue and other	(58,566)	(75,385)
Stock / (Unit)-based compensation expense	11,829	11,804
Gain on sale of real estate	(62)	(451,638)
Real estate and other impairment charges	89,538	4,875
Straight-line rent and other write-off (recovery)	2,192	(2,271)
Debt refinancing and unutilized financing costs		8,816
Tax rate changes	(7,305)
Other adjustments	(8,505)	(1,040)
Changes in:
Interest and rent receivables	(514)	(12,431)
Other assets	(2,493)	(41)
Accounts payable and accrued expenses	(15,696)	(21,648)
Deferred revenue	600	(7,646)
Net cash provided by operating activities	135,648	179,387
Investing activities
Cash paid for acquisitions and other related investments	(72,900)	(724,795)
Net proceeds from sale of real estate	100	1,711,608
Principal received on loans receivable	221,876	6,355
Investment in loans receivable	(50,000)	(10,414)
Construction in progress and other	(13,292)	(36,115)
Capital additions and other investments, net	(68,606)	(67,605)
Net cash provided by investing activities	17,178	879,034
Financing activities
Payments of term debt		(869,606)
Revolving credit facilities, net	95,919	(198,599)
Dividends paid	(176,580)	(176,494)
Lease deposits and other obligations to tenants	(2,691)	15,168
Stock vesting - satisfaction of tax withholdings	(5,554)	(27,919)
Payment of debt refinancing, deferred financing costs, and other financing activities	(219)	(6,366)
Net cash used for financing activities	(89,125)	(1,263,816)
Increase (decrease) in cash, cash equivalents, and restricted cash for period	63,701	(205,395)
Effect of exchange rate changes	2,927	(4,721)
Cash, cash equivalents, and restricted cash at beginning of period	241,538	461,882
Cash, cash equivalents, and restricted cash at end of period	308,166	251,766
Interest paid	116,436	111,012
Supplemental schedule of non-cash financing activities:
Dividends declared, unpaid	174,492	174,018
Cash, cash equivalents, and restricted cash are comprised of the following:
Cash and cash equivalents at beginning of period	235,668	459,227
Restricted cash, included in Other assets at beginning of period	$ 5,870	$ 2,655
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at beginning of period	$ 241,538	$ 461,882
Cash and cash equivalents at end of period	302,321	248,846
Restricted cash, included in Other assets at end of period	$ 5,845	$ 2,920
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at end of period	$ 308,166	$ 251,766
MPT Operating Partnership, L.P. [Member]
Operating activities
Net income	33,030	631,947
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	87,586	88,760
Amortization of deferred financing costs and debt discount	4,014	5,285
Straight-line rent revenue and other	(58,566)	(75,385)
Stock / (Unit)-based compensation expense	11,829	11,804
Gain on sale of real estate	(62)	(451,638)
Real estate and other impairment charges	89,538	4,875
Straight-line rent and other write-off (recovery)	2,192	(2,271)
Debt refinancing and unutilized financing costs		8,816
Tax rate changes	(7,305)
Other adjustments	(8,505)	(1,040)
Changes in:
Interest and rent receivables	(514)	(12,431)
Other assets	(2,493)	(41)
Accounts payable and accrued expenses	(15,696)	(21,648)
Deferred revenue	600	(7,646)
Net cash provided by operating activities	135,648	179,387
Investing activities
Cash paid for acquisitions and other related investments	(72,900)	(724,795)
Net proceeds from sale of real estate	100	1,711,608
Principal received on loans receivable	221,876	6,355
Investment in loans receivable	(50,000)	(10,414)
Construction in progress and other	(13,292)	(36,115)
Capital additions and other investments, net	(68,606)	(67,605)
Net cash provided by investing activities	17,178	879,034
Financing activities
Payments of term debt		(869,606)
Revolving credit facilities, net	95,919	(198,599)
Dividends paid	(176,580)	(176,494)
Lease deposits and other obligations to tenants	(2,691)	15,168
Stock vesting - satisfaction of tax withholdings	(5,554)	(27,919)
Payment of debt refinancing, deferred financing costs, and other financing activities	(219)	(6,366)
Net cash used for financing activities	(89,125)	(1,263,816)
Increase (decrease) in cash, cash equivalents, and restricted cash for period	63,701	(205,395)
Effect of exchange rate changes	2,927	(4,721)
Cash, cash equivalents, and restricted cash at beginning of period	241,538	461,882
Cash, cash equivalents, and restricted cash at end of period	308,166	251,766
Interest paid	116,436	111,012
Supplemental schedule of non-cash financing activities:
Dividends declared, unpaid	174,492	174,018
Cash, cash equivalents, and restricted cash are comprised of the following:
Cash and cash equivalents at beginning of period	235,668	459,227
Restricted cash, included in Other assets at beginning of period	$ 5,870	$ 2,655
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at beginning of period	$ 241,538	$ 461,882
Cash and cash equivalents at end of period	302,321	248,846
Restricted cash, included in Other assets at end of period	$ 5,845	$ 2,920
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at end of period	$ 308,166	$ 251,766